IL155997A0 - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- IL155997A0 IL155997A0 IL15599701A IL15599701A IL155997A0 IL 155997 A0 IL155997 A0 IL 155997A0 IL 15599701 A IL15599701 A IL 15599701A IL 15599701 A IL15599701 A IL 15599701A IL 155997 A0 IL155997 A0 IL 155997A0
- Authority
- IL
- Israel
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25250800P | 2000-11-22 | 2000-11-22 | |
PCT/US2001/051647 WO2003053331A2 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL155997A0 true IL155997A0 (en) | 2003-12-23 |
Family
ID=22956303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15599701A IL155997A0 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1392657A4 (en) |
JP (1) | JP2005513083A (en) |
KR (1) | KR20040004445A (en) |
CN (1) | CN1635903A (en) |
AR (1) | AR034278A1 (en) |
AU (1) | AU2001298052A1 (en) |
BR (1) | BR0115473A (en) |
CA (1) | CA2436850A1 (en) |
CZ (1) | CZ20031403A3 (en) |
HU (1) | HUP0301964A3 (en) |
IL (1) | IL155997A0 (en) |
MX (1) | MXPA03004542A (en) |
NO (1) | NO20032328L (en) |
PL (1) | PL366232A1 (en) |
UY (1) | UY27032A1 (en) |
WO (1) | WO2003053331A2 (en) |
ZA (1) | ZA200303848B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
US7071184B2 (en) | 2000-03-21 | 2006-07-04 | Smithkline Beecham Corporation | Protease inhibitors |
NZ522965A (en) * | 2000-06-14 | 2004-06-25 | Smithkline Beecham Corp | Protease inhibitors |
US20110092484A1 (en) | 2007-06-08 | 2011-04-21 | Nippon Chemiphar Co., Ltd. | Therapeutic or prophylactic agent for cerebral aneurysm |
EP2216047A4 (en) | 2007-10-24 | 2011-12-28 | Nat Univ Corp Tokyo Med & Dent | Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0104768A3 (en) * | 1998-12-23 | 2002-05-28 | Smithkline Beecham Corp | 4-amino-3-oxo-azepanes as protease inhibitors and pharmaceutical compositions containing the same |
US7071184B2 (en) * | 2000-03-21 | 2006-07-04 | Smithkline Beecham Corporation | Protease inhibitors |
NZ522965A (en) * | 2000-06-14 | 2004-06-25 | Smithkline Beecham Corp | Protease inhibitors |
-
2001
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/en unknown
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Application Discontinuation
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/en not_active Application Discontinuation
- 2001-11-19 PL PL01366232A patent/PL366232A1/en not_active Application Discontinuation
- 2001-11-19 IL IL15599701A patent/IL155997A0/en unknown
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/en not_active Application Discontinuation
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/en unknown
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/en unknown
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/en not_active Withdrawn
- 2001-11-19 CN CNA018220533A patent/CN1635903A/en active Pending
- 2001-11-20 AR ARP010105409A patent/AR034278A1/en unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/en not_active Application Discontinuation
-
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR0115473A (en) | 2004-09-28 |
AR034278A1 (en) | 2004-02-18 |
EP1392657A4 (en) | 2004-03-10 |
ZA200303848B (en) | 2004-06-28 |
CN1635903A (en) | 2005-07-06 |
WO2003053331A2 (en) | 2003-07-03 |
WO2003053331A3 (en) | 2003-11-13 |
NO20032328L (en) | 2003-07-02 |
CA2436850A1 (en) | 2003-07-03 |
UY27032A1 (en) | 2002-07-31 |
JP2005513083A (en) | 2005-05-12 |
HUP0301964A2 (en) | 2007-02-28 |
PL366232A1 (en) | 2005-01-24 |
KR20040004445A (en) | 2004-01-13 |
AU2001298052A1 (en) | 2003-07-09 |
NO20032328D0 (en) | 2003-05-22 |
HUP0301964A3 (en) | 2007-09-28 |
EP1392657A2 (en) | 2004-03-03 |
MXPA03004542A (en) | 2003-09-10 |
CZ20031403A3 (en) | 2003-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL150964A0 (en) | Protease inhibitors | |
GB0125445D0 (en) | Protease Inhibitors | |
IL215892A0 (en) | Peptidomimetic protease inhibitors | |
IL153421A0 (en) | Protease inhibitors | |
EP1235577A4 (en) | Protease inhibitors | |
EP1232155A4 (en) | Protease inhibitors | |
IL151087A0 (en) | Protease inhibitors | |
EP1229912A4 (en) | Protease inhibitors | |
EP1231921A4 (en) | Protease inhibitors | |
EP1229915A4 (en) | Protease inhibitors | |
EP1229914A4 (en) | Protease inhibitors | |
HK1043534A1 (en) | Protease inhibitors | |
EP1351930A4 (en) | Protease inhibitors | |
EP1173429A4 (en) | Protease inhibitors | |
EP1233771A4 (en) | Protease inhibitors | |
EP1229911A4 (en) | Protease inhibitors | |
EP1401453A4 (en) | Protease inhibitors | |
EP1231923A4 (en) | Protease inhibitors | |
HUP0301964A2 (en) | Protease inhibitors | |
IL155961A0 (en) | Cysteine protease inhibitors | |
EP1232154A4 (en) | Protease inhibitors | |
EP1231922A4 (en) | Protease inhibitors | |
AU6407701A (en) | Serine protease inhibitors | |
GB0009123D0 (en) | Protease inhibitor | |
ZA200207478B (en) | Protease inhibitors. |